The main mechanism of PP2A inactivation in cancer is via the overexpression of the endogenous PP2A inhibitors SET (Suvar/Enhancer of zeste/Trithorax) and CIP2A (Cancerous Inhibitor of PP2A) (69, 72, 73). The gene discussed is PTPA; the disease is cancer.